Skip to main content
Addgene

pCMV-Cyclin D1 Citations (10)

Originally described in: Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.
Watanabe H, Pan ZQ, Schreiber-Agus N, DePinho RA, Hurwitz J, Xiong Y Proc Natl Acad Sci U S A. 1998 Feb 17. 95(4):1392-7.
PubMed Journal

Articles Citing pCMV-Cyclin D1

Articles
SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination. Mittal MK, Singh K, Misra S, Chaudhuri G. J Biol Chem. 2011 Jan 7;286(1):469-79. doi: 10.1074/jbc.M110.164384. Epub 2010 Nov 2. PubMed
p16INK4a impairs homologous recombination-mediated DNA repair in human papillomavirus-positive head and neck tumors. Dok R, Kalev P, Van Limbergen EJ, Asbagh LA, Vazquez I, Hauben E, Sablina A, Nuyts S. Cancer Res. 2014 Mar 15;74(6):1739-51. doi: 10.1158/0008-5472.CAN-13-2479. Epub 2014 Jan 28. PubMed
Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells. Jia Y, Domenico J, Swasey C, Wang M, Gelfand EW, Lucas JJ. PLoS One. 2014 May 21;9(5):e97448. doi: 10.1371/journal.pone.0097448. eCollection 2014. PubMed
Epigenetically altered miR-193b targets cyclin D1 in prostate cancer. Kaukoniemi KM, Rauhala HE, Scaravilli M, Latonen L, Annala M, Vessella RL, Nykter M, Tammela TL, Visakorpi T. Cancer Med. 2015 Sep;4(9):1417-25. doi: 10.1002/cam4.486. Epub 2015 Jul 1. PubMed
MicroRNA-202 induces cell cycle arrest and apoptosis in lung cancer cells through targeting cyclin D1. Jiang J, Huang J, Wang XR, Quan YH. Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2278-84. PubMed
CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability. Dozier C, Mazzolini L, Cenac C, Froment C, Burlet-Schiltz O, Besson A, Manenti S. Oncogene. 2017 Jun 29;36(26):3781-3788. doi: 10.1038/onc.2016.506. Epub 2017 Feb 13. PubMed
Alternative Polyadenylation of PRELID1 Regulates Mitochondrial ROS Signaling and Cancer Outcomes. Gillen AE, Brechbuhl HM, Yamamoto TM, Kline E, Pillai MM, Hesselberth JR, Kabos P. Mol Cancer Res. 2017 Dec;15(12):1741-1751. doi: 10.1158/1541-7786.MCR-17-0010. Epub 2017 Sep 14. PubMed
MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN. Roth SA, Hald OH, Fuchs S, Lokke C, Mikkola I, Flaegstad T, Schulte J, Einvik C. Oncotarget. 2018 Apr 6;9(26):18160-18179. doi: 10.18632/oncotarget.24793. eCollection 2018 Apr 6. PubMed
CDK4 inhibition diminishes p53 activation by MDM2 antagonists. Sriraman A, Dickmanns A, Najafova Z, Johnsen SA, Dobbelstein M. Cell Death Dis. 2018 Sep 11;9(9):918. doi: 10.1038/s41419-018-0968-0. PubMed
miR-193b represses influenza A virus infection by inhibiting Wnt/beta-catenin signalling. Yang X, Zhao C, Bamunuarachchi G, Wang Y, Liang Y, Huang C, Zhu Z, Xu D, Lin K, Senavirathna LK, Xu L, Liu L. Cell Microbiol. 2019 May;21(5):e13001. doi: 10.1111/cmi.13001. Epub 2019 Jan 25. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.